PL316024A1 - Non-specific immunity activator prepared on the basis of various combinations of smallpox virus particles, process for preparing same and therapeutic application thereof - Google Patents

Non-specific immunity activator prepared on the basis of various combinations of smallpox virus particles, process for preparing same and therapeutic application thereof

Info

Publication number
PL316024A1
PL316024A1 PL95316024A PL31602495A PL316024A1 PL 316024 A1 PL316024 A1 PL 316024A1 PL 95316024 A PL95316024 A PL 95316024A PL 31602495 A PL31602495 A PL 31602495A PL 316024 A1 PL316024 A1 PL 316024A1
Authority
PL
Poland
Prior art keywords
basis
various combinations
virus particles
therapeutic application
preparing same
Prior art date
Application number
PL95316024A
Other versions
PL182132B1 (en
Inventor
Anton Mayr
Original Assignee
Anton Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Mayr filed Critical Anton Mayr
Publication of PL316024A1 publication Critical patent/PL316024A1/en
Publication of PL182132B1 publication Critical patent/PL182132B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Multipotent paramunity inducers are described which are based on combinations of poxvirus components derived from various poxviruses with paramunizing properties and which have been improved in terms of their potency and their paramunization-related activities as compared with the known paramunity inducers. The invention also relates to a method for preparing these multipotent paramunity inducers and to their use as drugs.
PL95316024A 1994-02-23 1995-01-17 Non-specific immunity activator prepared on the basis of various combinations of smallpox virus particles, process for preparing same and therapeutic application thereof PL182132B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4405841A DE4405841C1 (en) 1994-02-23 1994-02-23 Multipotent non-specific immunity inducers based on combinations of poxvirus components, processes for their preparation and their use as pharmaceuticals
PCT/EP1995/000160 WO1995022978A1 (en) 1994-02-23 1995-01-17 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament

Publications (2)

Publication Number Publication Date
PL316024A1 true PL316024A1 (en) 1996-12-23
PL182132B1 PL182132B1 (en) 2001-11-30

Family

ID=6511005

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95316024A PL182132B1 (en) 1994-02-23 1995-01-17 Non-specific immunity activator prepared on the basis of various combinations of smallpox virus particles, process for preparing same and therapeutic application thereof

Country Status (20)

Country Link
US (1) US6805870B1 (en)
EP (1) EP0669133B1 (en)
JP (1) JP2873880B2 (en)
KR (1) KR100196204B1 (en)
CN (1) CN1142187A (en)
AT (1) ATE153242T1 (en)
AU (1) AU690625B2 (en)
BR (1) BR9506882A (en)
CA (1) CA2182207C (en)
DE (2) DE4405841C1 (en)
DK (1) DK0669133T3 (en)
ES (1) ES2102081T3 (en)
FI (1) FI116557B (en)
GR (1) GR3023508T3 (en)
HU (1) HU220972B1 (en)
NO (1) NO319250B1 (en)
NZ (1) NZ278079A (en)
PL (1) PL182132B1 (en)
SI (1) SI0669133T1 (en)
WO (1) WO1995022978A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032029A1 (en) * 1996-02-28 1997-09-04 Bayer Aktiengesellschaft Parapoxviruses containing foreign dna, their production and their use in vaccines
PT885013E (en) * 1996-04-15 2002-01-30 Anton Mayr Prof Dr Med Vet Dr USE OF MULTI-POTENTIAL INDUCTORS BASED ON POXVIRUSES OR PARAPOXVIRUS ATENUATED AND NOT IMMUNOGENIC FOR THE MANUFACTURE OF MEDICINES
JPH1192390A (en) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc Agent for improving stressed state
US6641816B1 (en) 1998-06-26 2003-11-04 Aventis Pasteur S.A. Use of poxviruses as enhancer of specific immunity
DE19922407A1 (en) * 1999-05-14 2000-11-16 Bayer Ag Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
DK1180155T3 (en) * 1999-05-28 2009-02-16 Helmholtz Zentrum Muenchen Vector for integration of heterologous sequences into poxviral genomes
IL150736A0 (en) * 2000-03-14 2003-02-12 Mayr Anton Altered strain of the modified vaccinia virus ankara (mva)
DE10122451A1 (en) * 2000-07-11 2002-04-04 Bayer Ag Use of strains of the Parapoxvirus ovis for the production of antiviral and anti-cancer drugs
SI21171A (en) * 2000-07-11 2003-10-31 Bayer Aktiengesellschaft Use of strains of the parapox ovis virus against organ fibrosis
EE200300018A (en) * 2000-07-11 2004-10-15 Bayer Aktiengesellschaft Use of parapoxvirus ovis strains in the manufacture of antiviral and anticancer drugs
DE10122233A1 (en) * 2000-07-11 2002-01-24 Bayer Ag Use of strains of the Parapoxvirus ovis against organ fibrosis
EP1598425A1 (en) * 2000-11-23 2005-11-23 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US7628980B2 (en) * 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
US7097842B2 (en) 2000-11-23 2006-08-29 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
UA82466C2 (en) * 2001-07-18 2008-04-25 Бавариан Нордика А/С Method for intensification of chordopoxvirus amplification
CN101397574A (en) 2001-12-04 2009-04-01 巴法里安诺迪克有限公司 Flavivirus NS1 subunit vaccine
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
US6723329B2 (en) * 2001-12-07 2004-04-20 Board Of Regents, The University Of Texas System Use of parapox B2L protein to modify immune responses to administered antigens
AU2002353031A1 (en) 2001-12-07 2003-06-23 Bayer Corporation Use of parapox b2l protein to treat cancer and modify immune responses
ES2288609T5 (en) * 2002-04-19 2017-11-13 Bavarian Nordic A/S Modified vaccinia ankara virus for the vaccination of neonates
PL215169B1 (en) 2002-09-05 2013-10-31 Bavarian Nordic As Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
DE102004003572A1 (en) 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunity inducers based on attenuated rabbit myxomaviruses
CN103800382A (en) 2004-07-13 2014-05-21 爱库里斯股份有限两合公司 Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
DE102004046391A1 (en) * 2004-09-24 2006-04-06 Bioveta Ag New vaccine for veterinary and human medical prophylaxis and therapy
DE102005027956B4 (en) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Highly attenuated poxvirus strains, processes for their preparation and their use as paramunity inducers or for the production of vector vaccines
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3816139A1 (en) * 1987-10-17 1989-04-27 Bayer Ag METHOD FOR PRODUCING PARAMUNITY INDUCERS

Also Published As

Publication number Publication date
HU220972B1 (en) 2002-07-29
NO319250B1 (en) 2005-07-04
CN1142187A (en) 1997-02-05
DE4405841C1 (en) 1995-01-05
ES2102081T3 (en) 1997-07-16
NO963462L (en) 1996-08-20
DE59402826D1 (en) 1997-06-26
EP0669133B1 (en) 1997-05-21
HU9601947D0 (en) 1996-09-30
EP0669133A1 (en) 1995-08-30
AU1416795A (en) 1995-09-11
US6805870B1 (en) 2004-10-19
FI963277A (en) 1996-08-22
CA2182207A1 (en) 1995-08-31
PL182132B1 (en) 2001-11-30
SI0669133T1 (en) 1997-10-31
KR970701062A (en) 1997-03-17
HUT75545A (en) 1997-05-28
GR3023508T3 (en) 1997-08-29
CA2182207C (en) 2000-02-29
AU690625B2 (en) 1998-04-30
FI116557B (en) 2005-12-30
BR9506882A (en) 1997-08-19
ATE153242T1 (en) 1997-06-15
FI963277A0 (en) 1996-08-22
KR100196204B1 (en) 1999-06-15
NZ278079A (en) 1998-01-26
WO1995022978A1 (en) 1995-08-31
JPH09504803A (en) 1997-05-13
JP2873880B2 (en) 1999-03-24
DK0669133T3 (en) 1997-07-14

Similar Documents

Publication Publication Date Title
PL316024A1 (en) Non-specific immunity activator prepared on the basis of various combinations of smallpox virus particles, process for preparing same and therapeutic application thereof
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
WO1998055495A3 (en) Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
HU9603155D0 (en) Papillomavirus vaccines
AU4612093A (en) Soluble ligands for CD40
EP0835133A4 (en) Recombinant poxvirus-rabies compositions and combination compositions and uses
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
GEP20032902B (en) Mixture of Recombinant Vaccinia Vectors as Polyenv Vaccines for HIV
DE69525369T2 (en) CONTINUOUS POLYMERIZATION PROCESS OF POLYAMIDES
SE9704546D0 (en) Novel compounds
HUP9902429A2 (en) Modulators of tnf receptor associated factor (traf), their preparation and use
MX9702666A (en) New peptides with immunomodulatory effects.
UA35639C2 (en) Method for obtaining of composition of purified core protein of human papilloma virus.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
IL107674A0 (en) Multifunctional neurotrophic factors
PL330535A1 (en) Novel systems for transcutaneous administration of trimegestone, method of preparing them for use and their application as therapeutic agents
NZ332243A (en) The use of multipotent parapox immunity inducers from attenuated non-immunogenic pox viruses or parapox viruses in the manufacture of medicaments for treating multiple sclerosis
DE69726602D1 (en) Hepatitis b inhibitoren
AU7728296A (en) Hemoregulatory compounds
GB9314133D0 (en) New process

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110117